首页> 外文会议>Annual international conference of the IEEE engineering in medicine and biology society >Artificial cells containing genetically engineered E. coli DH5 cells for urea and ammonia removal in kidney and liver failure
【24h】

Artificial cells containing genetically engineered E. coli DH5 cells for urea and ammonia removal in kidney and liver failure

机译:含有遗传工程化大肠杆菌DH5细胞的人造细胞用于尿素和肝衰竭中的氨疹去除

获取原文

摘要

Describes a novel method of urea and ammonia removal using microencapsulated genetically engineered E. coli DH5 cells. In vitro, 100 mg of bacterial cells encapsulated in alginate-polylysine-alginate (APA) membrane, in their log phase state of growth, can lower 87.89/spl plusmn/2.25% of the plasma urea within 20 minutes and 99.99% in 30 minutes. The same amount of encapsulated bacteria is also capable of lowering ammonia from 975.14/spl plusmn/70.15 /spl mu/M/L to 81.151/spl plusmn/7.37 /spl mu/M/L in 30 minutes. This new approach is significantly more efficient than the presently available methods of urea and ammonia removal.
机译:描述了一种使用微胶囊化遗传工程化大肠杆菌DH5细胞进行尿素和氨的去除方法。体外,100mg包封在藻酸盐 - 聚氰基 - 藻酸盐(APA)膜中的细菌细胞,其日志相生长状态可以在20分钟内降低87.89 / SPL PLUSMN / 2.25%,在30分钟内为99.99%的血浆尿素。相同数量的包封细菌也能够在30分钟内将氨从975.14 / SPL PLUSMN / 70.15 / SPL MU / M / L PLUSMN / 7.37 / SPL MU / M / L.这种新方法比目前可用的尿素和氨移除方法更有效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号